News & Articles

This support will contribute to the measures against COVID-19, following provision of medical equipment and supplies, employee donations, and loans through NPO

Thermo Fisher Scientific’s ImmunoCAP Specific IgE alpha-Gal Allergen Component test helps clinicians pinpoint a potentially fatal allergy often resulting from tick bites

Discover how light scattering provides essential biophysical insight and reliable quantification of critical quality parameters for vaccine research, development, production and quality control

Partnership to co-commercialize pralsetinib, an investigational, precision therapy in late-stage development

AccuPlex™ SARS-CoV-2 Verification Panel and Reference Material Kit are now available with full SARS-CoV-2 viral genome coverage

Based on the results, the U.S.-based trial has been stopped, including in a second cohort of patients who received a higher dose of Kevzara (800 mg)

Partnerships, products, and solutions facilitate detection, research, and vaccine development to combat the SARS-CoV-2 virus

The “triple antibody” test will provide health professionals with an accurate indication of the presence of IgA, IgM and IgG COVID-19 antibodies within 10 minutes

ETH researchers have used computer simulations to classify the current activity of corona structures on the surface of Venus

Magnetic nanodiscs can be activated by an external magnetic field, providing a research tool for studying neural responses

This fund enables needy students to participate in the corona-related new online semester offers of Berlin's universities and colleges

Establishing a broad range of remotely accessible COVID-19 assays including biochemical profiling for COVID-19 drug targets

Paper published in npj Genomic Medicine demonstrates identification of more reportable CNVs with CytoSure v3 vs traditional array design

Rigaku will be live webcasting a 3-day Virtual Analytical X-ray Convention, taking place August 4-6, featuring live seminars on X-ray techniques and live instrument demonstrations.

Avacta to begin clinical validation of the high-throughput COVID-19 laboratory test in collaboration with the UK government CONDOR program

Interim data shows strong antibody and T-cell responses in all evaluated participants

Company also receives new FDA emergency use authorizations for use of self-collection molecular diagnostic kit on the Hologic and Roche platforms

xMAP SARS-CoV-2 Multi-Antigen IgG Assay is enabled by xMAP Technology, the gold standard for multiplexing serologic testing

Cambridge researchers have shown how rapid genome sequencing of virus samples and enhanced testing of hospital staff can help to identify clusters of healthcare-associated COVID-19 infections

The workflow is designed to minimize the potential for contamination of the food supply and risk to handlers and consumers